News

The U.S. Food and Drug Administration expanded its approval of Moderna's respiratory syncytial virus (RSV) vaccine on ...
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...
The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s ...
The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has ...
HHS Secretary Robert F. Kennedy Jr named 8 new members to the CDC’s Advisory Committee on Immunization Practices.
(NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345), the Company’s respiratory syncytial virus (RSV) vaccine, for the prevention of lower ...
The University of Washington’s Helen Chu, a leading voice in the COVID-19 pandemic, said she’s worried about where the panel ...
The FDA approved mResvia for the prevention of RSV in people ages 18 to 59 years who are at increased risk for severe disease.
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Cassidy’s Kennedy quagmire The Trump ...
State Halts License Suspension Efforts Against Hollywood Nursing Home: The California Public Health Department has dropped efforts to suspend the license of Brier Oak on Sunset after it determined the ...
In other developments, the ECDC today reported a slow rise in COVID activity in the Europe, which may partly reflect waning ...